Rapid Novor
Company Details
Status: Private
Employees: 101-250
Location:
Kitchener, Canada
Type:
sample
Technology:
sample
sample
sample
About: Rapid Novor Inc. is the world's leader in antibody protein sequencing technology. Specializing in the field of mass spectrometry-based proteomics, the team has developed the technology to directly sequence antibody proteins without needing to access the producing cell line. As a University of Waterloo spin-off, the company is building its technology portfolios based on the twenty years of scientific research and inventions from Dr. Bin Ma, co-founder and chief scientist. The company's REmAb™ antibody protein sequencing service has allowed for the accurate sequencing of any given antibody proteins on a routine basis. The company's WILD™ service is the first commercially available service that can accurately distinguish the isobaric Isoleucine and Leucine using mass spectrometry.
The company's mission is to advance life science for better human health with next generation protein sequencing.
For more information, visit www.rapidnovor.com. Follow the company on Twitter @rapidnovor.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Rapid Novor | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.